117 related articles for article (PubMed ID: 29773002)
21. Prognostic analysis of submucosa-invasive gastric cancer with lymph node metastasis.
Hanyu T; Matsuki A; Kosugi S; Ishikawa T; Nashimoto A; Yabusaki H; Aizawa M; Ichikawa H; Shimada Y; Hirose Y; Wakai T
Surgery; 2015 Apr; 157(4):716-22. PubMed ID: 25433728
[TBL] [Abstract][Full Text] [Related]
22. [Preoperative (neoadjuvant) chemotherapy in multimodality treatment concept of stomach carcinoma].
Meyer HJ; Jähne J; Wilke H; Pichlmayr R
Zentralbl Chir; 1995; 120(2):128-34. PubMed ID: 7709664
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of surgical margin status in gastric cancer patients.
Liang Y; Ding X; Wang X; Wang B; Deng J; Zhang L; Liang H
ANZ J Surg; 2015 Sep; 85(9):678-84. PubMed ID: 24438078
[TBL] [Abstract][Full Text] [Related]
24. Neoadjuvant chemoradiotherapy followed by D2 gastrectomy in locally advanced gastric cancer.
Kim MS; Lim JS; Hyung WJ; Lee YC; Rha SY; Keum KC; Koom WS
World J Gastroenterol; 2015 Mar; 21(9):2711-8. PubMed ID: 25759540
[TBL] [Abstract][Full Text] [Related]
25. Liver metastases from gastric carcinoma: A Case report and review of the literature.
Polkowska-Pruszyńska B; Rawicz-Pruszyński K; Ciseł B; Sitarz R; Polkowska G; Krupski W; Polkowski WP
Curr Probl Cancer; 2017; 41(3):222-230. PubMed ID: 28625333
[TBL] [Abstract][Full Text] [Related]
26. Perioperative chemotherapy for resectable gastroesophageal cancer: a single-center experience.
Molina R; Lamarca A; Martínez-Amores B; Gutiérrez A; Blázquez A; López A; Granell J; Álvarez-Mon M
Eur J Surg Oncol; 2013 Aug; 39(8):814-22. PubMed ID: 23755989
[TBL] [Abstract][Full Text] [Related]
27. Surgical care quality and oncologic outcome after D2 gastrectomy for gastric cancer.
Mrena J; Mattila A; Böhm J; Jantunen I; Kellokumpu I
World J Gastroenterol; 2015 Dec; 21(47):13294-301. PubMed ID: 26715812
[TBL] [Abstract][Full Text] [Related]
28. Prognostic Role of Conversion Surgery for Unresectable Gastric Cancer.
Fukuchi M; Ishiguro T; Ogata K; Suzuki O; Kumagai Y; Ishibashi K; Ishida H; Kuwano H; Mochiki E
Ann Surg Oncol; 2015 Oct; 22(11):3618-24. PubMed ID: 25663597
[TBL] [Abstract][Full Text] [Related]
29. Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single korean institute.
Moon YW; Jeung HC; Rha SY; Yoo NC; Roh JK; Noh SH; Kim BS; Chung HC
Ann Surg Oncol; 2007 Oct; 14(10):2730-7. PubMed ID: 17632757
[TBL] [Abstract][Full Text] [Related]
30. Vascular invasion as an independent predictor of poor prognosis in nonmetastatic gastric cancer after curative resection.
Li P; Ling YH; Zhu CM; Hu WM; Zhang XK; Luo RZ; He JH; Yun JP; Li YF; Cai MY
Int J Clin Exp Pathol; 2015; 8(4):3910-8. PubMed ID: 26097575
[TBL] [Abstract][Full Text] [Related]
31. Benefits of intra-operative systemic chemotherapy during curative surgery in patients with locally advanced gastric cancer.
Meng QB; Yu JC; Ma ZQ; Kang WM; Zhou L; Ye X
Chin Med J (Engl); 2013; 126(18):3493-8. PubMed ID: 24034096
[TBL] [Abstract][Full Text] [Related]
32. A phase II study of neoadjuvant chemotherapy with S-1 and cisplatin for stage III gastric cancer: KUGC03.
Okabe H; Hata H; Ueda S; Zaima M; Tokuka A; Yoshimura T; Ota S; Kinjo Y; Yoshimura K; Sakai Y;
J Surg Oncol; 2016 Jan; 113(1):36-41. PubMed ID: 26604064
[TBL] [Abstract][Full Text] [Related]
33. Early postoperative intraperitoneal chemotherapy following cytoreductive surgery in patients with very advanced gastric cancer.
Cheong JH; Shen JY; Song CS; Hyung WJ; Shen JG; Choi SH; Noh SH
Ann Surg Oncol; 2007 Jan; 14(1):61-8. PubMed ID: 17058123
[TBL] [Abstract][Full Text] [Related]
34. Adjuvant chemotherapy provided survival benefit for stage T2N0 gastric cancer with high-risk factors.
Wang Z; Yan J; Hu W; Zhang J; Huo B
Neoplasma; 2018; 65(4):592-598. PubMed ID: 29940758
[TBL] [Abstract][Full Text] [Related]
35. [Utilization of multimodal therapy concepts in stomach carcinoma in Germany].
Bösing NM; Heise JW; Röher HD
Zentralbl Chir; 2000; 125(4):341-7. PubMed ID: 10829314
[TBL] [Abstract][Full Text] [Related]
36. Phase 2 study of adjuvant chemotherapy with docetaxel, capecitabine, and cisplatin in patients with curatively resected stage IIIB-IV gastric cancer.
Yoon S; Yoo C; Ryu MH; Kang MJ; Ryoo BY; Park SR; Yook JH; Oh ST; Yoo MW; Kim BS; Kang YK
Gastric Cancer; 2017 Jan; 20(1):182-189. PubMed ID: 26661592
[TBL] [Abstract][Full Text] [Related]
37. Curative Gastrectomy with Perioperative Chemotherapy Improves the Survival for Unresectable Gastric Cancer.
Otowa Y; Suzuki S; Kanaji S; Harada H; Tanaka T; Yamamoto M; Matsuda Y; Oshikiri T; Nakamura T; Kakeji Y
Anticancer Res; 2018 Apr; 38(4):2363-2368. PubMed ID: 29599362
[TBL] [Abstract][Full Text] [Related]
38. Outcomes of adjuvant chemoradiotherapy after a radical gastrectomy and a D2 node dissection for gastric adenocarcinoma.
Leong CN; Chung HT; Lee KM; Shakespeare TP; Mukherjee RK; Wong LC; Lu JJ; Tey J; Lim R; So JB; Back MF
Cancer J; 2008; 14(4):269-75. PubMed ID: 18677137
[TBL] [Abstract][Full Text] [Related]
39. [Conversion Surgery for Stage IV Gastric Cancer].
Konishi T; Kosuga T; Ichikawa D; Komatsu S; Okamoto K; Konishi H; Shiozaki A; Fujiwara H; Arita T; Morimura R; Murayama Y; Kuriu Y; Ikoma H; Nakanishi M; Otsuji E
Gan To Kagaku Ryoho; 2017 Nov; 44(12):1208-1210. PubMed ID: 29394583
[TBL] [Abstract][Full Text] [Related]
40. Adverse prognostic impact of perioperative allogeneic transfusion on patients with stage II/III gastric cancer.
Kanda M; Kobayashi D; Tanaka C; Iwata N; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Nomoto S; Murotani K; Fujiwara M; Kodera Y
Gastric Cancer; 2016 Jan; 19(1):255-63. PubMed ID: 25563579
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
